Results 201 to 210 of about 51,667 (257)

External validation of a novel HR-pQCT based fracture risk assessment tool (μFRAC) in a male cohort: the osteoporotic fractures in men (MrOS) study. [PDF]

J Bone Miner Res
Bugbird AR, Burghardt AJ, Langsetmo L, Ensrud KE, Bouxsein ML, Kiel DP, Boyd SK, Whittier DE.   +7 more
europepmc   +1 more source

Myeloproliferative neoplasm subtypes have distinct impact on risk of incident osteoporosis and osteoporotic fractures. [PDF]

Blood Adv
Lee MH, Wang Y, Cronin A, Tramontano AC, Weeks LD, Hobbs GS.   +5 more
europepmc   +1 more source

Diagnostic value and role in promoting fracture healing of deregulated circulating miR-204 in patients with osteoporotic fractures. [PDF]

J Orthop Surg Res
Cheng Z, Liu J, Shao C, Li J, Chen J, Han L, Jiang X, Shang L, Cao J.   +8 more
europepmc   +1 more source

Association of high-density lipoprotein with P1NP and β-CTX in hospitalized patients with osteoporotic fractures: a retrospective cross-sectional study. [PDF]

Front Endocrinol (Lausanne)
Zhu CB, Zhou P, Lu K, Li C, Wei YL, Jin J, Hu WB, Gao YJ.   +7 more
europepmc   +1 more source

Metabolomic biomarkers of rest-activity rhythms in older men: results from the Osteoporotic Fractures in Men (MrOS) study. [PDF]

Sleep
Zhang L, Viola Lee KA, Stone K, LaCroix A, Shadyab AH, Yaffe K, Redline S, Kado D, Yeung CHC, Wang S, Huang Y, Xiao Q.   +11 more
europepmc   +1 more source

Correction: The association between the triglyceride-glucose index and bone turnover markers in osteoporotic fractures patients aged 50 and above who are hospitalized for surgical intervention: a retrospective cross-sectional study. [PDF]

Front Endocrinol (Lausanne)
Xu J, Guo SH, Xu MZ, Li C, Gong YQ, Lu K.   +5 more
europepmc   +1 more source

The diagnostic and therapeutic potential of miR-3149 in osteoporotic fractures through SMAD4. [PDF]

J Orthop Surg Res
Xu G, Yang Z, Zeng S, Dong Y, Huang L.
europepmc   +1 more source

Editorial: Digital technology in the diagnosis and treatment of osteoporotic fractures in the elderly. [PDF]

Front Med (Lausanne)
Hu J.
europepmc   +1 more source

Real-world evidence indicates romosozumab use is associated with a greater reduction in osteoporotic fractures than PTH (1-34) analogs in women. [PDF]

Biol Sex Differ
Lu KH, Wang SI, Yang SF.
europepmc   +1 more source